C
Compass Therapeutics Inc.
NASDAQ:CMPX
Compass Therapeutics Inc.
NASDAQ:CMPX
Price:
5.21
USD
-2.25%
Market Closed
Market Cap:
$938.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
Bolt Projects Holdings Inc
NASDAQ:BSLK
|
US |
|
First Service Holding Ltd
HKEX:2107
|
CN |
|
S
|
Sporting Clube de Portugal Futebol SAD
ELI:SCP
|
PT |
|
Komercni Banka as
PSE:KOMB
|
CZ |
|
P
|
Peninsula Group Ltd
TASE:PEN
|
IL |
|
Sinocelltech Group Ltd
SSE:688520
|
CN |
|
B
|
Bhang Inc
CNSX:BHNG
|
CA |
|
First Internet Bancorp
NASDAQ:INBK
|
US |
|
Shanghai Xintonglian Packaging Co Ltd
SSE:603022
|
CN |
|
I
|
Intertainment AG
XETRA:ITN
|
DE |
Balance Sheet
Balance Sheet Decomposition
Compass Therapeutics Inc.
Compass Therapeutics Inc.
Balance Sheet Decomposition is not available for
Compass Therapeutics Inc.
Compass Therapeutics Inc.
Balance Sheet
Compass Therapeutics Inc.
Compass Therapeutics Inc.
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
58
|
25
|
47
|
145
|
35
|
24
|
43
|
31
|
|
| Cash Equivalents |
58
|
25
|
47
|
145
|
35
|
24
|
43
|
31
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
152
|
128
|
83
|
178
|
|
| Other Current Assets |
1
|
1
|
3
|
3
|
8
|
1
|
6
|
1
|
|
| Total Current Assets |
59
|
26
|
50
|
147
|
195
|
154
|
133
|
210
|
|
| PP&E Net |
5
|
4
|
1
|
6
|
5
|
3
|
7
|
9
|
|
| PP&E Gross |
5
|
4
|
1
|
6
|
5
|
3
|
7
|
9
|
|
| Accumulated Depreciation |
4
|
6
|
6
|
5
|
6
|
6
|
6
|
7
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Total Assets |
65
N/A
|
30
-53%
|
52
+71%
|
154
+196%
|
200
+30%
|
157
-21%
|
140
-11%
|
220
+56%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
1
|
1
|
1
|
3
|
4
|
2
|
2
|
|
| Accrued Liabilities |
3
|
3
|
2
|
10
|
13
|
4
|
7
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
6
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
9
|
10
|
10
|
11
|
16
|
8
|
9
|
14
|
|
| Long-Term Debt |
11
|
9
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
3
|
2
|
1
|
6
|
9
|
|
| Total Liabilities |
20
N/A
|
19
-2%
|
12
-37%
|
14
+14%
|
18
+31%
|
8
-54%
|
15
+82%
|
23
+50%
|
|
| Equity | |||||||||
| Common Stock |
132
|
133
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
87
|
122
|
151
|
234
|
273
|
315
|
365
|
431
|
|
| Additional Paid In Capital |
0
|
0
|
191
|
374
|
455
|
464
|
490
|
628
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
45
N/A
|
11
-75%
|
40
+253%
|
140
+251%
|
182
+30%
|
149
-18%
|
125
-16%
|
197
+57%
|
|
| Total Liabilities & Equity |
65
N/A
|
30
-53%
|
52
+71%
|
154
+196%
|
200
+30%
|
157
-21%
|
140
-11%
|
220
+56%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
52
|
52
|
51
|
101
|
126
|
128
|
138
|
178
|
|
Switch to:
Switch to:
See Also
Discover More
